Investor Presentation - July 2017
Filed with ASX · · 41 pages · English
Any forward looking statements in this presentation have been prepared on the basis of a number of assumptions which may prove incorrect and the current intentions, plans, expectations and beliefs about future events are subject to risks, uncertainties and other factors, many of which are outside Optiscan Imaging Ltd’s control. Important factors that could cause actual results to differ materially
Optiscan Imaging Limited on 6ix
In the deck
Earlier from Optiscan Imaging
- Optiscan Appoints Exclusive North American Distributor
- Amended Appendix 4D
- Appendix 4D and Financial Statements - 31 Dec 2016
- Cleansing Prospectus
- Prospectus - Share and Option Issues approved at AGM
Later from Optiscan Imaging
- ViewnVivo Update
- Share Placement and Underwritten Share Purchase Plan
- Preliminary Final Report - Appendix 4E
- An update from the Chairman
- Carl Zeiss Meditec to unveil in vivo Digital Biopsy Tool
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging